Skip to Content
Get key facts and figures about chronic dry eye

Cysteamine ophthalmic Pregnancy and Breastfeeding Warnings

Cysteamine ophthalmic is also known as: Cystaran

Cysteamine ophthalmic Pregnancy Warnings

Use during pregnancy is recommended only if the potential benefit justifies the potential risk to the fetus. US FDA pregnancy category: C

Animal studies have revealed evidence of teratogenicity and fetotoxicity. Teratogenic findings included cleft palate, kyphosis, heart ventricular septal defects, microcephaly, and exencephaly; fetotoxicity resulted in intrauterine death and growth retardation. This drug reduced the fertility of adult animals and the survival of their offspring at an oral dose 1.7 times the recommended human dose (RHD), but had no effect on fertility and reproductive performance at an oral dose 0.4 times the RHD. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Cysteamine ophthalmic Breastfeeding Warnings

A decision should be made whether to discontinue breastfeeding or to discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available. Comments: The effects in the nursing infant are unknown; however, animal studies have revealed this drug has the potential to cause developmental toxicity in nursing offspring.

See references

References for pregnancy information

  1. "Product Information. Cystaran (cysteamine ophthalmic)." Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD.

References for breastfeeding information

  1. "Product Information. Cystaran (cysteamine ophthalmic)." Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.